Lizbé Koekemoer is a Team leader at The Centre for Medicines Discovery (CMD) at University of Oxford, where she is responsible for the CMD’s crystallography research facility (PX-SRF). The CMD is a multi-disciplinary Institute which focuses on translational activities to catalyze the discovery of new medicines. Lizbé has a strong interest in crystallography and biophysical techniques for the use in early-stage drug discovery. Before joining the CMD, she worked as a postdoctoral researcher in Frank von Delft’s group at the Structural Genomics Consortium (SGC).